Guggenheim Boosts Incyte (NASDAQ:INCY) Price Target to $92.00
Incyte (NASDAQ:INCY – Free Report) had its price objective upped by Guggenheim from $86.00 to $92.00 in a research report report published on Monday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other research firms have also issued reports on INCY. Bank of America upped their […]
More Stories
Michael J. Hartnett Sells 503 Shares of RBC Bearings Incorporated (NYSE:RBC) Stock
RBC Bearings Incorporated (NYSE:RBC – Get Free Report) CEO Michael J. Hartnett sold 503 shares of the company’s stock in...
Eric L. Gerratt Sells 18,731 Shares of Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER) Stock
Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER – Get Free Report) CFO Eric L. Gerratt sold 18,731 shares of the business’s...
Resource Capital Fund VI L.P. Sells 350,000 Shares of Talon Metals Corp. (TSE:TLO) Stock
Talon Metals Corp. (TSE:TLO – Get Free Report) insider Resource Capital Fund VI L.P. sold 350,000 shares of the firm’s...
Nicole Sherman Acquires 2,500 Shares of Riverview Bancorp, Inc. (NASDAQ:RVSB) Stock
Riverview Bancorp, Inc. (NASDAQ:RVSB – Get Free Report) CEO Nicole Sherman acquired 2,500 shares of the company’s stock in a...
Noralee Bradley Purchases 300 Shares of Nutrien Ltd. (TSE:NTR) Stock
Nutrien Ltd. (TSE:NTR – Get Free Report) Senior Officer Noralee Bradley purchased 300 shares of the firm’s stock in a...
Toews Agility Shares Dynamic Tactical Income ETF (THY) To Go Ex-Dividend on September 19th
Toews Agility Shares Dynamic Tactical Income ETF (BATS:THY – Get Free Report) announced a dividend on Wednesday, September 18th, NASDAQ...